168 related articles for article (PubMed ID: 28797691)
21. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
22. Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder.
Matchynski-Franks JJ; Susick LL; Schneider BL; Perrine SA; Conti AC
PLoS One; 2016; 11(5):e0155759. PubMed ID: 27186643
[TBL] [Abstract][Full Text] [Related]
23. Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice.
O'Neill MF; Osborne DJ; Woodhouse SM; Conway MW
J Psychopharmacol; 2001 Mar; 15(1):18-22. PubMed ID: 11277603
[TBL] [Abstract][Full Text] [Related]
24. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant-Like Effects of Hesperidin in Animal Model of Post-Traumatic Stress Disorder.
Lee B; Choi GM; Sur B
Chin J Integr Med; 2021 Jan; 27(1):39-46. PubMed ID: 32445019
[TBL] [Abstract][Full Text] [Related]
27. Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder.
Song D; Ge Y; Chen Z; Shang C; Guo Y; Zhao T; Li Y; Wu N; Song R; Li J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):190-200. PubMed ID: 29510167
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
Zvozilova A; Bukatova S; Koprdova R; Mach M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
[TBL] [Abstract][Full Text] [Related]
29. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.
Serova LI; Tillinger A; Alaluf LG; Laukova M; Keegan K; Sabban EL
Neuroscience; 2013 Apr; 236():298-312. PubMed ID: 23376740
[TBL] [Abstract][Full Text] [Related]
30. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
[TBL] [Abstract][Full Text] [Related]
31. Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder.
Malikowska-Racia N; Popik P; Sałat K
Behav Brain Res; 2020 Mar; 381():112380. PubMed ID: 31765726
[TBL] [Abstract][Full Text] [Related]
32. Analysis of main constituents and mechanisms underlying antidepressant-like effects of Xiaochaihutang in mice.
Zhang K; Wang F; Yang JY; Wang LJ; Pang HH; Su GY; Ma J; Song SJ; Xiong ZL; Wu CF
J Ethnopharmacol; 2015 Dec; 175():48-57. PubMed ID: 26318746
[TBL] [Abstract][Full Text] [Related]
33. Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder.
Enman NM; Arthur K; Ward SJ; Perrine SA; Unterwald EM
Biol Psychiatry; 2015 Dec; 78(12):871-9. PubMed ID: 26115790
[TBL] [Abstract][Full Text] [Related]
34. Umbelliferone modulates depression-like symptoms by altering monoamines in a rat post-traumatic stress disorder model.
Lee B; Yeom M; Shim I; Lee H; Hahm DH
J Nat Med; 2020 Mar; 74(2):377-386. PubMed ID: 31755013
[TBL] [Abstract][Full Text] [Related]
35. Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter.
Andersen J; Ladefoged LK; Wang D; Kristensen TN; Bang-Andersen B; Kristensen AS; Schiøtt B; Strømgaard K
ACS Chem Neurosci; 2015 Nov; 6(11):1892-900. PubMed ID: 26389667
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.
Haddad Y; Heger Z; Adam V
ACS Chem Neurosci; 2016 Nov; 7(11):1607-1613. PubMed ID: 27596073
[TBL] [Abstract][Full Text] [Related]
37. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
Haenisch B; Bönisch H
Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
[TBL] [Abstract][Full Text] [Related]
38. Venlafaxine plus melatonin ameliorate reserpine-induced depression-like behavior in zebrafish.
Tang YQ; Li ZR; Zhang SZ; Mi P; Chen DY; Feng XZ
Neurotoxicol Teratol; 2019; 76():106835. PubMed ID: 31518687
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
40. An activity model for novel antidepressants that interact with the serotonin transporter (SERT).
Pissurlenkar RS; Dhir A; Kessar SV; Kulkarni SK; Coutinho EC
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):228-37. PubMed ID: 21919867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
